CN Patent

CN104592218B — 一种泰地唑胺的合成方法

Assigned to Jiangsu Alpha Pharmaceutical Co ltd · Expires 2015-11-04 · 11y expired

What this patent protects

本发明公开了一种泰地唑胺的合成方法，属于药物合成领域。本发明以4-溴-3-氟苯胺为起始原料，反应制备得到新型抗菌药物泰地唑胺。本发明提供了一种新的工业化合成选择方式，同时由于反应原料易于得到，反应条件温和，对环境污染小，有益于工业化大规模生产。

USPTO Abstract

本发明公开了一种泰地唑胺的合成方法，属于药物合成领域。本发明以4-溴-3-氟苯胺为起始原料，反应制备得到新型抗菌药物泰地唑胺。本发明提供了一种新的工业化合成选择方式，同时由于反应原料易于得到，反应条件温和，对环境污染小，有益于工业化大规模生产。

Drugs covered by this patent

Patent Metadata

Patent number
CN104592218B
Jurisdiction
CN
Classification
—
Expires
2015-11-04
Drug substance claim
No
Drug product claim
No
Assignee
Jiangsu Alpha Pharmaceutical Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.